Aldeyra Therapeutics (ALDX) Q1 2026 Earnings

27FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.28
-0.22
-0.17
-0.11

Details

Expected EPS
-0.14
Actual EPS
-0.11
Surprise EPS
0.03
Surprise Percent
+21.43%

Description

Aldeyra Therapeutics (ALDX) has reported earnings of -0.11 per share for Q1 2026.

0 Comments

Share your thoughts